Day: March 13, 2026

13 March 2026 LEI: 2138003QW2ZAYZODBU23 LSE Code: 2UKS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE FTSE 100 2X DAILY SHORT SECURITIESISIN: IE00B94QKF15PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt about what action you should take, you are recommended to consult your independent financial adviser. If you have sold or transferred all of your WisdomTree FTSE 100 2x Daily Short Securities (the “Affected Securities”) of WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”), please send this document, together with the accompanying form of proxy, at once to the purchaser or transferee...

Kfar Saba, Israel, March 13, 2026 (GLOBE NEWSWIRE) — ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, today announced it has received a new purchase order from an Israeli defense entity for its DefendAir Counter-Unmanned Aerial Systems (Counter-UAS) solution. This new order reinforces the growing trust and operational reliance on ParaZero’s DefendAir platform by multiple strategic defense entities within Israeli defense ecosystem. The order includes the delivery of an evaluation kit including DefendAir’s net pods live exercise and training to support rapid operational deployment and maximize readiness. DefendAir is a multi-layered soft-hard kill Counter-UAS system that deploys...

NEW YORK, March 13, 2026 (GLOBE NEWSWIRE) — WeRide Inc. (“WeRide” or the “Company”) (Nasdaq: WRD; HKEx: 0800), a global leader in autonomous driving technology, today announced that each of the proposed resolutions submitted for shareholders’ approval (the “Proposed Resolutions”) as set forth in the notice of extraordinary general meeting, notice of Class A meeting and notice of Class B meeting, each dated February 6, 2026, Beijing time, have been adopted at the meetings held in Guangzhou, Guangdong Province, China today. After the adoption of the Proposed Resolutions, all corporate authorizations and actions contemplated thereunder are approved, including, among other things, that (i) the Company’s existing memorandum and articles of associations are amended and restated by their deletion in their entirety and by the substitution...

Seligson & Co Fund Management Company PlcSTOCK EXCHANGE NOTICE 13.3.2026 SELIGSON & CO OMX HELSINKI 25 EXCHANGE TRADED FUND UCITS ETF: CHANGE OF THE RULES OF THE FUND The rule change does not require any action on the part of the unit holder. The rule change will not affect the fund’s investment policy, and the change will not result in tax consequences for the unit holder. The Finnish Financial Supervisory Authority has approved the rules on 5 March 2026, and they become effective from 16 April 2026. Why is the change made? The new regulation* obliges fund management companies to select at least two means of liquidity management defined in the regulation for the funds they manage. Regulatory liquidity management methods have been added to the rules The liquidity management methods chosen by Seligson & Co Fund Management...

Positions Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the platform’s clinical development Provides Lifeward access to up to $47 million of capital HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 13, 2026 (GLOBE NEWSWIRE) — Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global leader in innovative medical technology to transform the lives of people with physical limitations or disabilities, today announced that its shareholders approved the issuances of ordinary shares of the Company in connection with closing of the Company’s previously announced strategic partnership agreement with Oramed Pharmaceuticals Inc. (Nasdaq: ORMP). “This is a defining moment in...